Login

Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
James Clifton, CEO of The MISSION Group, discusses company insights in an executive interview with Mirriad Advertising.
00:10:00
Lexington Gold Acquires Majority Stake in White Rivers Exploration, Eyeing Millions of Ounces in South Africa | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Transforming Business Strategies with Data-Driven Customer Segmentation | William H Rogers Jr, CEO , SunTrust Banks.
00:10:00
Interview with manager of Alfred Berg Gambak, Petter Tusvik | Tomas Scherp, CEO, Alfred Berg Kapitalforvaltning ASAS OF 29 FEB 2024
00:10:00
An overview of 2S Metal Pcl in brief | Sombat Leeswadtrakul, CEO, 2S Metal PCL
00:10:00
"Fundamental Focus: Exploring India's Banking Revival and Automotive Sector Recovery"
00:10:00
Strategies for Managing Risk and Return in Private Equity | John Connaughton, Co-Managing Partner , Bain Capital .
00:10:00
Automotive 2025: Global Trends and Their Impact on Lubricants | William Downey - Partner, Roland Berger
00:10:00
Small Business Success: Insights from Barry McCarthy | Barry McCarthy - CEO of Deluxe Corporation
00:10:00
Exploring Market Performance and Trends | Joanna Arnold, Chief Executive Officer, Access Intelligence PLCACC:LSE
00:10:00
Creating a world where companies and services work together|CEO, Biprogy Inc
00:10:00
Discover develop and deliver innovative therapies for the treatment of advanced solid tumors and other major diseases|David J. Mazzo,President,Caladrius Biosciences Inc

© 2026 Nehu